CytomX Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTMX research report →
About the company
CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications.
- CEO
- Sean A. McCarthy
- IPO
- 2015
- Employees
- 119
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $614.35M
- P/E
- -10.58
- P/S
- 17.29
- P/B
- 2.12
- EV/EBITDA
- -10.20
- Div Yield
- 0.00%
- Gross Margin
- 99.29%
- Op Margin
- -181.92%
- Net Margin
- -166.40%
- ROE
- -36.61%
- ROIC
- -19.70%
- Revenue
- $76.20M · -44.82%
- Net Income
- $-17,368,000 · -154.50%
- EPS
- $-0.15 · -139.47%
- Op Income
- $-22,364,000
- FCF YoY
- 12.40%
- 52W High
- $8.21
- 52W Low
- $1.72
- 50D MA
- $3.61
- 200D MA
- $4.12
- Beta
- 2.08
- Avg Volume
- 4.46M
Get TickerSpark's AI analysis on CTMX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Su Zhen | other | 59,000 |
| Jun 17, 26 | Young Matthew P. | other | 59,000 |
| Jun 17, 26 | Mohindru Mani | other | 59,000 |
| Jun 17, 26 | Meyers James R | other | 59,000 |
| Jun 17, 26 | Gilbert Halley E | other | 59,000 |
| Jun 17, 26 | Ashworth Alan | other | 59,000 |
| Jun 17, 26 | Jones Elaine V | other | 59,000 |
| Jun 15, 26 | Ogden Christopher | sell | 1,624 |
| Mar 17, 26 | Chu Yu-Waye | sell | 21,279 |
| Mar 17, 26 | McCarthy Sean A. | sell | 118,969 |
Our CTMX coverage
Recent articles, reports, and earnings notes.
No research on CTMX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTMX report →Similar companies
Peers in the same neighborhood.